William Kinnett
Acute Care · Cordele, GANPI 1194383075
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,277 of the $5,881 with a category attached, or 72.7%. 16 manufacturers reported payments, led by Gilead at 57.2% of the total. Reporting peaked in 2022 at $2,505 and has fallen 99.1% since, to $23 in 2025. Among acute care clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $43.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$3K
- Viiv Healthcare Company$834
- Janssen Products, LP$328
- AstraZeneca$265
- Merck$217
- Sumitomo Pharma America, Inc.$125
- plus $748 from 10 others
What the payments were for
- Consulting fees$1,07018%
- Travel & lodging$4307%
- Food & beverage$4,27773%
- Education$1052%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 52 | $3,365 |
| Viiv Healthcare Company | 43 | $834 |
| Janssen Products, LP | 3 | $328 |
| AstraZeneca | 3 | $265 |
| Merck | 11 | $217 |
| Sumitomo Pharma America, Inc. | 1 | $125 |
| Novo Nordisk | 1 | $115 |
| Johnson & Johnson | 7 | $114 |
| AbbVie | 4 | $94 |
| Paratek Pharmaceuticals, Inc. | 4 | $77 |
| Exact Sciences | 1 | $76 |
| Boehringer Ingelheim | 1 | $75 |
| Grifols USA, LLC | 1 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $59 |
| Dexcom, Inc. | 2 | $48 |
| Organogenesis Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,881 in reported general payments places this provider in the 95th percentile of 679 acute care providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 136 | $565,118 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 17 | $89,083 |
| DescovyEmtricitabine/Tenofov Alafenam | 16 | $39,357 |
| MicafunginMicafungin Sodium | 15 | $6,267 |
| Vancomycin Hcl | 12 | $2,084 |
| Rifampin | 11 | $1,131 |
| CeftriaxoneCeftriaxone Sodium | 17 | $655 |
| Doxycycline Hyclate | 29 | $433 |
| Cephalexin | 23 | $374 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $147 |
| FenofibrateFenofibrate Nanocrystallized | 11 | $99 |
| Fluconazole | 22 | $94 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $3,365 | $604,476152 claims |
| Janssen Products, LPSymtuza | $328 | $89,08317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 679 acute care providers in Georgia.
Other acute care in Cordele
- Darryl TurnerRinggold$21K
- Bryce CowgillCumming$16K
- Stacy CreelSavannah$15K
- Susan BeitzellAthens$13K
- Crystal KuhnCumming$12K
- Mark ClarkGainesville$10K
- Sarah WymanAtlanta$10K
- Jeffrey DillerAustell$10K
- Ayeshia PowellAtlanta$10K
- Mitzi WilliamsGainesville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.